Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03395808 · ClinicalTrials.gov registry record · Phase 3
Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery
A Phase 3 study, sponsored by Avenue Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 251
- Enrollment target
NCT03395808 is a Phase 3 study that has completed, run by Avenue Therapeutics. The registered enrollment target is 251 participants.
The verdict
NCT03395808, a Phase 3 study, has completed, sponsored by Avenue Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 251 participants
- Enrollment target
Study Summary
The study evaluates the safety of IV tramadol managing post-operative pain following surgery.
Interventions
- DRUG Tramadol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2019-05-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03395808
The ClinicalTrials.gov registry entry for NCT03395808 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avenue Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tramadol is the first listed.
NCT03395808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03395808 about?
NCT03395808 is a clinical study titled "Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery". The study evaluates the safety of IV tramadol managing post-operative pain following surgery.
What is the current status of trial NCT03395808?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 251 participants. The study started on 2017-12-22. Estimated completion is 2019-05-06.
What interventions are being tested in trial NCT03395808?
The interventions under investigation include: Tramadol (DRUG).
Who is sponsoring clinical trial NCT03395808?
This trial is sponsored by Avenue Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.